Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 22, Issue 1, Pages 45-57
Publisher
Informa UK Limited
Online
2017-11-17
DOI
10.1080/14728222.2018.1406924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
- (2017) Karoline V. Gleixner et al. HAEMATOLOGICA
- Targeting Aberrant Signaling in Myeloid Malignancies
- (2017) Rob Sellar et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Epigenetics in Myeloproliferative Neoplasms
- (2017) Suzanne McPherson et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
- (2017) Yuankai Shi et al. Journal of Hematology & Oncology
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
- (2017) Karoline V. Gleixner et al. HAEMATOLOGICA
- Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
- (2016) Elisa Rumi et al. BLOOD
- Emerging treatments for classical myeloproliferative neoplasms
- (2016) Alessandro M. Vannucchi et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
- (2016) Cristina López et al. BRITISH JOURNAL OF HAEMATOLOGY
- STAT5A is regulated by DNA damage via the tumor suppressor p53
- (2016) Utpal K. Mukhopadhyay et al. CYTOKINE
- NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML
- (2016) Ashok Kumar Jayavelu et al. EXPERIMENTAL HEMATOLOGY
- T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
- (2016) Carla Casulo et al. JNCI-Journal of the National Cancer Institute
- A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis
- (2016) S Verstovsek et al. LEUKEMIA
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- COSMIC: somatic cancer genetics at high-resolution
- (2016) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development
- (2016) François Lemonnier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of proto-oncogenes by disruption of chromosome neighborhoods
- (2016) D. Hnisz et al. SCIENCE
- Molecular Mechanism of Mutant CALR-Mediated Transformation
- (2016) R. F. Stanley et al. Cancer Discovery
- Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
- (2016) Jerome Bourgeais et al. Oncotarget
- Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia
- (2016) Etienne Danis et al. Cell Reports
- Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma
- (2016) Staci L. Haney et al. PLoS Genetics
- T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
- (2016) Carla Casulo et al. JNCI-Journal of the National Cancer Institute
- Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice
- (2016) Madeleine Themanns et al. Scientific Reports
- The aggressive peripheral T-cell lymphomas: 2015
- (2015) James O. Armitage AMERICAN JOURNAL OF HEMATOLOGY
- A three-signal model of T-cell lymphoma pathogenesis
- (2015) Ryan A. Wilcox AMERICAN JOURNAL OF HEMATOLOGY
- The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF- B positive feedback loop in peripheral T-cell lymphoma
- (2015) R. L. Boddicker et al. BLOOD
- Variegated RHOA mutations in adult T-cell leukemia/lymphoma
- (2015) Y. Nagata et al. BLOOD
- IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma
- (2015) C. Wang et al. BLOOD
- Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
- (2015) Ramona Crescenzo et al. CANCER CELL
- The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
- (2015) I. V. Litvinov et al. CLINICAL CANCER RESEARCH
- A comprehensive review of pacritinib in myelofibrosis
- (2015) Srdan Verstovsek et al. Future Oncology
- Genetic characterization of T-PLL reveals two major biologic subgroups andJAK3mutations as prognostic marker
- (2015) Anna Stengel et al. GENES CHROMOSOMES & CANCER
- Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
- (2015) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia
- (2015) E Andersson et al. LEUKEMIA
- STAT5A regulates DNMT3A in CD34+/CD38− AML cells
- (2015) Asako Takeuchi et al. LEUKEMIA RESEARCH
- Integrated molecular analysis of adult T cell leukemia/lymphoma
- (2015) Keisuke Kataoka et al. NATURE GENETICS
- Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome
- (2015) Mark J. Kiel et al. Nature Communications
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
- (2015) Can Küçük et al. Nature Communications
- Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma
- (2015) Britt Lauenborg et al. Oncotarget
- Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
- (2015) Nina A. Sibbesen et al. Oncotarget
- The aggressive peripheral T-cell lymphomas: 2013
- (2015) James O. Armitage AMERICAN JOURNAL OF HEMATOLOGY
- A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion
- (2014) Wei Huang et al. ACS Chemical Biology
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
- (2014) Neha Bhagwat et al. BLOOD
- GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
- (2014) T. Wang et al. BLOOD
- Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
- (2014) P. Lundberg et al. BLOOD
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
- (2014) J. Iqbal et al. BLOOD
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles
- (2014) Jing Tang et al. CURRENT PHARMACEUTICAL DESIGN
- The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
- (2014) O. R. Bandapalli et al. HAEMATOLOGICA
- Molecular genetics of peripheral T-cell lymphomas
- (2014) Pier Paolo Piccaluga et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Cutaneous T Cell Lymphoma Expresses Immunosuppressive CD80 (B7-1) Cell Surface Protein in a STAT5-Dependent Manner
- (2014) Q. Zhang et al. JOURNAL OF IMMUNOLOGY
- Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia
- (2014) A M Eiring et al. LEUKEMIA
- Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas
- (2014) A Nicolae et al. LEUKEMIA
- Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway
- (2014) P P Piccaluga et al. LEUKEMIA
- Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
- (2014) M Kontro et al. LEUKEMIA
- Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis
- (2014) J H Schatz et al. LEUKEMIA
- Ruxolitinib and DNA methyltransferase-inhibitors: a foray into combination regimens in myelofibrosis
- (2014) Naval Daver et al. LEUKEMIA & LYMPHOMA
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
- (2014) Hae Yong Yoo et al. NATURE GENETICS
- Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
- (2014) Mamiko Sakata-Yanagimoto et al. NATURE GENETICS
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
- (2014) Teresa Palomero et al. NATURE GENETICS
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation
- (2014) M Girardot et al. ONCOGENE
- Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
- (2014) Abbarna A. Cumaraswamy et al. ACS Medicinal Chemistry Letters
- Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
- (2014) M A Laginestra et al. Blood Cancer Journal
- Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice
- (2014) H Muto et al. Blood Cancer Journal
- A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
- (2013) O. Odejide et al. BLOOD
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
- (2013) Katharina Kopp et al. CELL CYCLE
- Signaling networks of Rho GTPases in cell motility
- (2013) Samer Hanna et al. CELLULAR SIGNALLING
- Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727
- (2013) Qifang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutations and prognosis in primary myelofibrosis
- (2013) A M Vannucchi et al. LEUKEMIA
- PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis
- (2013) A Berger et al. LEUKEMIA
- Dual PI3K/AKT/mTOR Inhibitor BEZ235 Synergistically Enhances the Activity of JAK2 Inhibitor against Cultured and Primary Human Myeloproliferative Neoplasm Cells
- (2013) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Chemotherapeutic Advancements in Peripheral T-Cell Lymphoma
- (2013) Nishitha M. Reddy et al. SEMINARS IN HEMATOLOGY
- Pathology of Peripheral T-Cell Lymphomas: Where Do We Stand?
- (2013) Philippe Gaulard et al. SEMINARS IN HEMATOLOGY
- Genetic Basis of MPN: Beyond JAK2-V617F
- (2013) Nicole C. C. Them et al. Current Hematologic Malignancy Reports
- Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice
- (2012) C. Walz et al. BLOOD
- Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon- 2a specifically targets JAK2V617F-positive polycythemia vera cells
- (2012) M. Lu et al. BLOOD
- Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters
- (2012) F. Lemonnier et al. BLOOD
- IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma
- (2012) R. A. Cairns et al. BLOOD
- Genetic and epigenetic alterations of myeloproliferative disorders
- (2012) Jelena D. Milosevic et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation
- (2012) Celeste Holz-Schietinger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
- (2012) Francesco d'Amore et al. JOURNAL OF CLINICAL ONCOLOGY
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells
- (2012) E Cholez et al. LEUKEMIA
- Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling
- (2012) Sangkil Nam et al. Molecular Oncology
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
- (2012) Lambert Busque et al. NATURE GENETICS
- PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
- (2012) Daniela Laimer et al. NATURE MEDICINE
- TET2andDNMT3AMutations in Human T-Cell Lymphoma
- (2012) Lucile Couronné et al. NEW ENGLAND JOURNAL OF MEDICINE
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia
- (2011) A. Slupianek et al. BLOOD
- Peripheral T-cell lymphoma
- (2011) F. M. Foss et al. BLOOD
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
- (2011) Stacey L Fossey et al. BMC CANCER
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- (2011) Cyril Quivoron et al. CANCER CELL
- JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
- (2011) Fan Liu et al. CANCER CELL
- DNA Methylation and SETDB1/H3K9me3 Regulate Predominantly Distinct Sets of Genes, Retroelements, and Chimeric Transcripts in mESCs
- (2011) Mohammad M. Karimi et al. Cell Stem Cell
- Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer
- (2011) Katrin Friedbichler et al. HEPATOLOGY
- Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
- (2011) Grace-Ifeyinwa Onimoe et al. INVESTIGATIONAL NEW DRUGS
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity
- (2011) Brent D. G. Page et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Therapeutic Options in Anaplastic Large Cell Lymphoma: Molecular Targets and Immunological Tools
- (2011) O. Merkel et al. MOLECULAR CANCER THERAPEUTICS
- p53 Lesions in Leukemic Transformation
- (2011) Ashot Harutyunyan et al. NEW ENGLAND JOURNAL OF MEDICINE
- MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a
- (2011) Yanqi Chang et al. Nature Communications
- A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs
- (2010) Elena Crisà et al. ANNALS OF HEMATOLOGY
- Inhibiting aberrant Stat3 function with molecular therapeutics
- (2010) Sina Haftchenary et al. ANTI-CANCER DRUGS
- The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease
- (2010) C. Dierks et al. CANCER RESEARCH
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation
- (2010) Margaret Rush et al. Epigenetics
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
- (2010) Charlotte M Niemeyer et al. NATURE GENETICS
- Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
- (2010) Jianyong Chen et al. ACS Medicinal Chemistry Letters
- Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
- (2009) Steven Fletcher et al. Biochemistry and Cell Biology
- NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
- (2009) Y.-X. Cui et al. BLOOD
- Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor
- (2009) C. Pecquet et al. BLOOD
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
- (2009) J. Iqbal et al. BLOOD
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening
- (2008) Wenshan Hao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
- (2008) V. R. Fantin et al. CANCER RESEARCH
- Discovery of Chromone-Based Inhibitors of the Transcription Factor STAT5
- (2008) Judith Müller et al. CHEMBIOCHEM
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
- (2008) A L Feldman et al. LEUKEMIA
- PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
- (2008) J Shen et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started